Download FREE Report Sample
Download Free sampleArthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory diseases
Arthritis Monoclonal Antibodies Market contains market size and forecasts of Arthritis Monoclonal Antibodies in Global, including the following market information:
Global Arthritis Monoclonal Antibodies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Arthritis Monoclonal Antibodies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Remicade Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Arthritis Monoclonal Antibodies include AbbVie Inc, F. Hoffmann-La Roche Ltd, Novartis, Johnson & Johnson(Janssen), Pfizer Inc, Mylan, Genentech, GSK and AstraZeneca PLC. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Arthritis Monoclonal Antibodies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Arthritis Monoclonal Antibodies Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Arthritis Monoclonal Antibodies Market Segment Percentages, by Type, 2021 (%)
Remicade
Humira
Enbrel
Rituxan
Orencia
Actemra
Simponi
Cimzia
Global Arthritis Monoclonal Antibodies Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Arthritis Monoclonal Antibodies Market Segment Percentages, by Application, 2021 (%)
Rheumatoid Arthritis
Osteoarthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Others
Global Arthritis Monoclonal Antibodies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Arthritis Monoclonal Antibodies Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Arthritis Monoclonal Antibodies revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Arthritis Monoclonal Antibodies revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie Inc
F. Hoffmann-La Roche Ltd
Novartis
Johnson & Johnson(Janssen)
Pfizer Inc
Mylan
Genentech
GSK
AstraZeneca PLC
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
